期刊文献+

三阴性乳腺癌的临床病理特点及治疗研究 被引量:2

Clinical pathologic characteristics and progress of Research on Triple-Negative Breast Cancer
下载PDF
导出
摘要 目的探讨三阴性乳腺癌患者的临床病理特点和临床研究进展。方法收集近年来国内、外有关TNBC的临床研究的文献并作综述。结果TNBC患者除手术治疗外,化疗是其主要的全身治疗手段,肿瘤大小和淋巴结状态是影响预后的独立因素。结论通过加强对TNBC的研究,可能为其治疗提供新的思路。 Objective To analyze the clinicopathological features and summarize the progress of clinical research on t riple-negative breast cancer (TNBC) . Methods Domestic and international publications on the study of TNBC in recent years were collected and reviewed. Results The patient s with TNBC were younger , and their prognosis was poorer . Besides operation ,chemotherapy was the major therapeutic tool for them. The factors which were found to compromise overall survival were turner size,lymph node status,stage, vascular invasion and nerve invasion in the univariate analysis.Tumor size.Conclusion The study on TNBC may bring a new way for therapy.
作者 陈蓉
机构地区 青海大学医学院
出处 《医学信息》 2009年第12期2986-2988,共3页 Journal of Medical Information
关键词 乳腺癌 三阴 临床特点 治疗 Breast neoplasm Triple-negative Clinical feature Treatment
  • 相关文献

参考文献11

  • 1Reis-Filho JS, Tutt AN.Triple negative tumors:a critical review [J].Hi stopathology .2008,52( 1 ) 108 - 18.
  • 2Nielsen TO, Hsu FD, Jensen K, et al.Immunohistochemical and clinical charaterization of the Basal-like subtype of invasive breast carcinoma[J].Clin Cancer Res,2004,10(16):5367-5374.
  • 3Liedtke C,Mazouni C,Hess KR,et al.Response to Neoadjuvant Therapy and long-term survival in patients with triple-negative brest cancer [J].J Clin Oncol, 2008; 26 (8) : 1275-1281.
  • 4Turner N,Tutt A , Ashworth A.Hallmarks of BRCAness in sporadic cancers[j].Nat Rev Cancer.2004,g(10):814-9.
  • 5Dent R,Trudeau M,Pritchard KI,et al.Triple-negative brest cancer: clinical features and paltems Of recurrenve [J].Chn Cancer Res, 2007,13 : 4429-4434.
  • 6Carlson RW, Moench S J, Hammond ME,et al.HER2 testing in breast cancer:NCCN Task Force report and recommendations.J Natl Compr Canc Netw,2006,4 Suppl 3:S1-22.
  • 7Keam B ,Im SA , Kim HJ , et al . Prognostic impact of clinieopat hologic parameters in stage Ⅱ/Ⅲ breast cancer treated wit hneoadjuvant docetaxel and doxorubicin chemotherapy : paradoxical features of the triple negative breast cancer [J] . BMC Cancer,2007,7:203.
  • 8Falo C,Moreno A.Vareia M,Lloveras B,Figueras A,Escobedo A.HER- 2/neustatus and response to CMF:retrospective study in a series of operable breastcancer treated with primary CMF chemotherapy.J Cancer Res Ctin Oncol.2007Jul;133(7):423-9.Epub 2007 Jan 24.
  • 9Quinn JE,Kennedy RD,Mullan PB,Gilmore PM,Carty M,Johnston PG, Harkin DP.BRCAI functions as a differential modulator of chemotherapy-induced apoptosis.Cancer Res.2003 Oct 1;63(19):6221-8.
  • 10Gluz O , Nitz UA , Harbeck N , et al . West German Study Group. Triple-negative high-risk breast cancer derives particular benefit from dose intensification of adjuvant cheroot herapy :result s of WSG AM201 trial [J ] . Ann Oncol . 2008;19(5):861.

同被引文献18

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部